Delivery Order N6833508D0019-0002

The National Institute on Drug Abuse (NIDA) awarded a delivery order valued at $324,420 to PPD Development LP on June 17, 2024, for research and development supporting clinical studies under the Blueprint MedTech program. This task order, designated as Task Order 02, runs through June 16, 2029, and focuses specifically on clinical study protocol development. The contract carries a firm fixed price structure with no set-aside designation and will be performed at PPD Development LP's facility in...

This task order is for Sri International to manufacture the sterile bulk product TLC-ART101 (2 liters) in full compliance with current good manufacturing practice regulations. TLC-ART101 is a targeted long-acting combination antiretroviral therapy consisting of the antiretrovirals lopinavir, ritonavir, and a third undisclosed antiretroviral. The National Institute of Allergy and Infectious Diseases, a component of the Department of Health and Human Services National Institutes of Health,...

This is a delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to IIT Research Institute (IITRI), a non-profit contract research organization. The $1,259,678.78 contract is to provide support for the preclinical development of an endoxifen gel, including pharmacology, toxicology, and safety studies to support an Investigational New Drug (IND) application. This contract is part of the NCI's PREVENT...

The Food and Drug Administration awarded a no-cost modification to PPD Development LP on September 24, 2024, to extend the period of performance for BAA-FY24C3CP5, "Understanding Heterogeneity in Preferences for Clinical Trial Participation in Diverse Patient Populations," through April 13, 2026. This Definitive Contract, valued at $1.3M and structured as a Time and Materials engagement, supports FDA's research objectives by examining factors that influence clinical trial enrollment...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order valued at $21.6 million to PPD Development LP for Division of AIDS (DAIDS) monitoring services supporting the Phase III PHOENIX study (A5300B/I2003B). This contract, awarded December 15, 2025, with an ultimate completion date of December 14, 2028, will be performed in Cape Fear, North Carolina. The award utilizes a cost-plus-fixed-fee pricing structure with no set-aside designation and represents a child...

This federal contract award to PPD Development LP, a global contract research organization (CRO), provides regulatory consulting assistance for a medical device developer under the Blueprint MedTech program. The $370,621 cost-plus-fixed-fee contract includes research and development for clinical studies, pre-submission assessment, and package preparation. The award is issued by the National Institute on Drug Abuse, a civilian agency, and is not set aside. PPD Development LP is a subsidiary of...

The National Cancer Institute awarded a firm fixed-price delivery order to IIT Research Institute for $1.4 million to support topical resatorvid development for nonmelanoma skin cancer prevention. The task order, issued on September 21, 2020, with an ultimate completion date of January 31, 2026, is performed in Chicago, Illinois. This delivery order operates under the PREVENT Preclinical Drug Development Program, a $150 million Indefinite Delivery/Indefinite Quantity contract vehicle that...

The U.S. Food and Drug Administration (FDA) has awarded a $811,680.97 firm-fixed price contract to Research Triangle Institute (RTI International), a non-profit research organization, to provide services supporting a study titled "Incorporating Women's Experiences and Prioritization of Treatment Outcomes into Regulatory Decision-Making for Medical Devices for Women's Health: Application of Patient Experience and Preference Research to Genitourinary Syndrome of Menopause." This...

The Department of the Army Medical Command awarded a firm fixed-price delivery order contract to PPD Development LP, a global contract research organization, to provide analysis of alternatives for peripheral nerve repair incorporating regenerative medicine technologies in support of the U.S. Army Medical Materiel Development Activity. The $163,971 contract has an October 31, 2018 completion date and is not set aside. PPD Development LP has experience providing clinical trial and research...

This is a delivery order issued under a $35 million Indefinite Delivery Contract (IDC) between Actuated Medical, Inc. (a woman-owned small business based in Bellefonte, Pennsylvania) and the National Institute on Drug Abuse (NIDA). The contract supports the Blueprint MedTech (BPMT) Initiative, which aims to develop innovative medical technologies for nervous system disorders. This specific delivery order, valued at $81,702, is for research and development services related to biocompatibility...